Cargando…
Lead optimization of novel quinolone chalcone compounds by a structure–activity relationship (SAR) study to increase efficacy and metabolic stability
Many agents targeting the colchicine binding site in tubulin have been developed as potential anticancer agents. However, none has successfully made it to the clinic, due mainly to dose limiting toxicities and the emergence of multi-drug resistance. Chalcones targeting tubulin have been proposed as...
Autores principales: | Knockleby, James, Djigo, Aïcha Dede, Lindamulage, Indeewari Kalhari, Karthikeyan, Chandrabose, Trivedi, Piyush, Lee, Hoyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566451/ https://www.ncbi.nlm.nih.gov/pubmed/34732782 http://dx.doi.org/10.1038/s41598-021-01058-z |
Ejemplares similares
-
Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and MRP1 function
por: Lindamulage, I. Kalhari, et al.
Publicado: (2017) -
Evaluation of anticancer properties of a decoction containing Adenanthera pavonina L. and Thespesia populnea L.
por: Lindamulage, Indeewari K. S., et al.
Publicado: (2016) -
Evaluation of phytochemical composition and antioxidant capacity of a decoction containing Adenanthera pavonina L. and Thespesia populnea L.
por: Silva, Indeewari Kalhari, et al.
Publicado: (2011) -
A Novel Dialkylamino-Functionalized Chalcone, DML6, Inhibits Cervical Cancer Cell Proliferation, In Vitro, via Induction of Oxidative Stress, Intrinsic Apoptosis and Mitotic Catastrophe
por: Len, Jenna M., et al.
Publicado: (2021) -
Cytotoxic and Anti-Plasmodial Activities of Stephania dielsiana Y.C. Wu Extracts and the Isolated Compounds
por: Knockleby, James, et al.
Publicado: (2020)